Primus In News
How to ensure sustainability and wider stakeholder acceptability in NLEM revisions
07-12-2022
Nilaya Varma, CEO and Managing Director, Primus Partners shares his thoughts on the 4th revision of the National List of Essential Medicines, in particular releasing frequent revisions to the list as well as providing greater financial incentives to pharma companies.
Explore Related Insights
- How will farmers earn more in the face of climate change
- Primus Partners Facilitated the Grounding of INR 200+ crore Investment for Indian Textile Legacy Conglomerate
- Project Management Unit for Regional Tourism Development Scheme under Govt. of Maharashtra
- ASSOCHAM – Consolidated recommendations to manage the impact of COVID-19
